LRP8 and Alzheimer disease: The authors of this study proposed a very interesting and innovative therapeutic approach to correct ApoER2 exon 19 splicing by vertebral injections of antisense oligonucleotides that prevent the exclusion of exon 19 and improved learning and memory in a mouse model of AD.